Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3331862 | Hematology/Oncology Clinics of North America | 2007 | 21 Pages |
Abstract
In 1978, the term “monoclonal gammopathy of undetermined significance” (MGUS) was introduced. MGUS is defined as a serum monoclonal (M) protein less than 3.0 g/dL; less than 10% plasma cells in the bone marrow, if done; little or no M protein in the urine; and absence of lytic bone lesions, anemia, hypercalcemia or renal insufficiency. This article discusses the recognition, prevalence, natural history, and progression of MGUS. Management of the disease is discussed along with its association with other disorders. Information on smoldering multiple myeloma is included.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Robert A. Kyle, S. Vincent Rajkumar,